Hotline 24/7: 0909384389

Share links:

Abiomed announces PROTECT III clinical data for protected PCI with Impella

Ngày 08/10/2019 08:26 | Lượt xem: 1426

Abiomed has announced the results of PROTECT III, an ongoing, prospective, single-arm US Food and Drug Administration (FDA) post-market approval (PMA) study for Impella 2.5 and Impella CP in high-risk percutaneous coronary intervention (PCI). PROTECT III follows the PROTECT II randomised controlled trial.

A press release from the company highlights that PROTECT III demonstrated a reduction in the primary endpoint of death, stroke, myocardial infarction and repeat procedures at 90 days with Impella-supported protected PCI, compared to PROTECT II.

The findings of the interim analysis on 898 patients were announced at the Transcatheter Cardiovascular Therapeutics conference (TCT 2019; 24–29 September, San Francisco, USA) by Jeffrey J Popma (Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA).

According to Abiomed, the PROTECT series of FDA clinical studies—PROTECT I, PROTECT II, and PROTECT III—is the largest-ever FDA study of haemodynamically supported high-risk PCI patients, and Impella is the most studied mechanical circulatory support device in the history of the FDA. The series has enrolled 1,366 patients as of July 2019, and includes the only FDA randomised controlled trial ever conducted for haemodynamically supported high-risk PCI. PROTECT III includes 898 patients enrolled at 45 sites in the USA between March 2017 and July 2019.

The press release states that patients in PROTECT III are statistically older (71 years), include more women (26%) and non-Caucasians (33%), received longer support and had more complex procedures with more vessels treated than patients in PROTECT II. Despite this, the 90-day major adverse cardiac and cerebrovascular events (MACCE) rate in PROTECT III is lower than the intra-aortic balloon pump (IABP) control arm from PROTECT II. The composite MACCE rate in the IABP arm was 31%, compared to the Impella 2.5 and Impella CP arm at 16.8% (p<0.0001).

In the press release, Popma comments: “Based on the learnings from the PROTECT studies, decisions to provide haemodynamic support during PCI should be made in the context of providing complete revascularisation, and patient outcomes should include in-hospital and out-of-hospital improvements, Prior studies have demonstrated it is important to achieve complete revascularisation because it can result in a 30–50% reduction in MACCE, compared to incomplete revascularisation.”

Source CardiovascularNews

Duc Tin Clinic

Tin tức liên quan

Vesteck completes first-in-human use of several Suture-Tight devices

Age is just a number: Individual patient data meta-analysis probes safety of CEA in the elderly

Artificial intelligence can predict risk of complications after endovascular aneurysm repair

Bluegrass Vascular announces Journal of Vascular Surgery paper reporting use of Surfacer system

Vascular access creation: EndoAVF keeps future options open, but is not a replacement for surgical fistulas

SUPPORT CONSULTANT

CUSTOMER REVIEWS

• I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

  I sincerely thank you !. Tel: 0938303275

• Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

  Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

• As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

• The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

• I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search

News

Customer support